KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesR&D In ProcessReceivables - NetReceivables - Other
Ratios

Eli Lilly (LLY) Receivables - Net (2016 - 2025)

Eli Lilly's Receivables - Net history spans 17 years, with the latest figure at $17.8 billion for Q4 2025.

  • For Q4 2025, Receivables - Net rose 61.37% year-over-year to $17.8 billion; the TTM value through Dec 2025 reached $17.8 billion, up 61.37%, while the annual FY2025 figure was $17.8 billion, 61.37% up from the prior year.
  • Receivables - Net reached $17.8 billion in Q4 2025 per LLY's latest filing, up from $16.1 billion in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $17.8 billion in Q4 2025 to a low of $5.6 billion in Q1 2021.
  • Average Receivables - Net over 5 years is $9.1 billion, with a median of $7.7 billion recorded in 2023.
  • Peak YoY movement for Receivables - Net: rose 3.34% in 2022, then surged 61.37% in 2025.
  • A 5-year view of Receivables - Net shows it stood at $6.7 billion in 2021, then grew by 3.34% to $6.9 billion in 2022, then skyrocketed by 31.82% to $9.1 billion in 2023, then grew by 21.07% to $11.0 billion in 2024, then soared by 61.37% to $17.8 billion in 2025.
  • Per Business Quant, the three most recent readings for LLY's Receivables - Net are $17.8 billion (Q4 2025), $16.1 billion (Q3 2025), and $14.2 billion (Q2 2025).